XELODA Side Effects

6924300-6 | Muscle Spasms
on Aug 11, 2010 Female patient from UNITED STATES , weighting 106.0 lb, was diagnosed with biliary neoplasm and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms. Xeloda dosage: 1000mg Bid Po.

6924162-7 | Aphagia, Blister, Dehydration, Oral Pain, Renal Failure Acute
Patient was taking Xeloda (View Usage). Patient had the following side effects: aphagia, blister, dehydration, oral pain, renal failure acute on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 176.0 lb, was diagnosed with colon cancer and. Xeloda dosage: 1250 Mg/m2 Daily Po. Patient was hospitalized.

6923283-2 | Ventricular Fibrillation
Adverse event was reported on Aug 09, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: ) . Location: CZECH REPUBLIC , 40 years of age, After Xeloda was administered, patient had the following side effects: ventricular fibrillation. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6923263-7 | Auricular Perichondritis
on Aug 09, 2010 Male patient from CHINA , 50 years of age, weighting 187.4 lb, was diagnosed with rectal cancer and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: auricular perichondritis. Xeloda dosage: .


6923165-6 | Back Pain, Chest Pain, Compression Fracture, Decreased Appetite, Diarrhoea, Enzyme Inhibition, Malaise, Myalgia, Nausea
on Aug 05, 2010 Male patient from JAPAN , weighting 88.18 lb, was diagnosed with colon cancer metastatic, eye infection fungal and was treated with Xeloda (View Usage). Patient had the following side effects: back pain (What is back pain?), chest pain (What is chest pain?), compression fracture, decreased appetite, diarrhoea, enzyme inhibition, malaise, myalgia, nausea (What is nausea?). Xeloda dosage: . During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), ELPLAT (View Elplat Review and Elplat Label ), DANTRIUM (View Dantrium Review and Dantrium Label ), MYONAL (View Myonal Review and Myonal Label ), KYTRIL (View Kytril Review and Kytril Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ). Patient was hospitalized.

6923144-9 | Altered State Of Consciousness, Leukoencephalopathy
Patient was taking Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: altered state of consciousness, leukoencephalopathy on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , weighting 83.78 lb, was diagnosed with large intestine carcinoma and. Xeloda dosage: . During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), MORPHINE HYDROCHLORIDE (Dosage Form: Peroral Liquid Preparation) (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6921108-2 | Colitis Ischaemic, Haemorrhage, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Aug 03, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: ) was diagnosed with large intestine carcinoma, psychosomatic disease and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: colitis ischaemic, haemorrhage, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with ELPLAT (Note: Dosage Is Uncertain.) (View Elplat Review and Elplat Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6919551-0 | Palmar-plantar Erythrodysaesthesia Syndrome
on Aug 10, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with breast cancer metastatic and was treated with Xeloda (View Usage). Patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome. Xeloda dosage: Not Provided.

6916671-1 | Mucosal Inflammation
on Jul 30, 2010 Female patient from NETHERLANDS , 65 years of age, was diagnosed with rectal cancer and was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: mucosal inflammation. Xeloda dosage: .

6916653-X | Loss Of Consciousness, Ventricular Extrasystoles, Ventricular Fibrillation
Patient was taking Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, ventricular extrasystoles, ventricular fibrillation on Aug 03, 2010 from JAPAN Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with breast cancer recurrent and. Xeloda dosage: .

6915189-X | Acute Myocardial Infarction
Adverse event was reported on Aug 05, 2010 by a Male patient taking Xeloda (View Usage) (Dosage: 75000 Mg) . Location: UNITED STATES , weighting 264.1 lb, Patient had the following side effects: acute myocardial infarction. During the same period patient was treated with ERBITUX (2925 Mg) (View Erbitux Review and Erbitux Label ), ELOXATIN (585 Mg) (View Eloxatin Review and Eloxatin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6913815-2 | Malignant Neoplasm Progression
on Jul 30, 2010 Female patient from UNITED STATES , 61 years of age, was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: malignant neoplasm progression. Xeloda dosage: . Patient was hospitalized.

6910549-5 | Palmar-plantar Erythrodysaesthesia Syndrome
on Jul 16, 2010 Female patient from UNITED STATES , weighting 218.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: palmar-plantar erythrodysaesthesia syndrome. Xeloda dosage: Taken For 2 Weeks.

6908326-4 | Rash, Stomatitis Necrotising
Patient was taking Xeloda (View Usage). Patient had the following side effects: rash (What is rash?), stomatitis necrotising on Aug 03, 2010 from RUSSIAN FEDERATION Additional patient health information: Male patient , 60 years of age, . Xeloda dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

6908290-8 | Nephrotic Syndrome
Adverse event was reported on Jul 28, 2010 by a Male patient taking Xeloda (View Usage) (Dosage: ) . Location: SWITZERLAND , 62 years of age, After Xeloda was administered, patient had the following side effects: nephrotic syndrome. During the same period patient was treated with TILUR (View Tilur Review and Tilur Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6905923-7 | Metastases To Meninges
on Jul 26, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with gastric cancer and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to meninges. Xeloda dosage: The 5th Cycle According To Eox Protocol. During the same period patient was treated with EPIRUBICIN (The 5th Cycle According To Eox Protocol) (View Epirubicin Review and Epirubicin Label ), OXALIPLATINE (The 5th Cycle According To Eox Protocol) (View Oxaliplatine Review and Oxaliplatine Label ).

6900272-5 | Jaundice, Liver Disorder
on Jul 23, 2010 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with rectal cancer metastatic and was treated with Xeloda (View Usage). Patient had the following side effects: jaundice (What is jaundice?), liver disorder. Xeloda dosage: 2 Weeks Administration Followed By 1 Week Rest. During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), GASTER (View Gaster Review and Gaster Label ), PYRIDOXAL CALCIUM PHOSPHATE (Reported As Aderoxal) (View Pyridoxal Calcium Phosphate Review and Pyridoxal Calcium Phosphate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SLOW K (View Slow-k Review and Slow-k Label ), MAGMITT (View Magmitt Review and Magmitt Label ).

6900266-X | Ejection Fraction Decreased, Therapeutic Response Decreased
Patient was taking Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: ejection fraction decreased, therapeutic response decreased on Jul 21, 2010 from CANADA Additional patient health information: Female patient , 76 years of age, . Xeloda dosage: . During the same period patient was treated with HERCEPTIN (Frequency: Weekly) (View Herceptin Review and Herceptin Label ), TAXOL (Frequency: Weekly) (View Taxol Review and Taxol Label ).

6900255-5 | Palmar-plantar Erythrodysaesthesia Syndrome, Purpura
Adverse event was reported on Jul 26, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: 7 Tablets Of 500 Mg. 14 Day Cycle) was diagnosed with lupus vasculitis, gastric ulcer and. Location: GREECE , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: palmar-plantar erythrodysaesthesia syndrome, purpura. During the same period patient was treated with PLAQUENIL (View Plaquenil Review and Plaquenil Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6900243-9 | Dihydropyrimidine Dehydrogenase Deficiency, Leukopenia, Mucosal Inflammation, Skin Toxicity
on Jul 26, 2010 Male patient from FRANCE , 83 years of age, was treated with Xeloda (View Usage). Patient had the following side effects: dihydropyrimidine dehydrogenase deficiency, leukopenia, mucosal inflammation, skin toxicity. Xeloda dosage: For 14 Days.

6900206-3 | Acute Respiratory Failure, Decreased Appetite, Dizziness, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome, Pneumonia Aspiration
on Jul 23, 2010 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with colon cancer recurrent and was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: acute respiratory failure, decreased appetite, dizziness (What is dizziness?), nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome, pneumonia aspiration. Xeloda dosage: It Was Reported That One Administering Weekly Holiday Medicine For Two Weeks.. During the same period patient was treated with ELPLAT (Form: Injection, Note: Dosage Is Uncertain) (View Elplat Review and Elplat Label ).

6894968-1 | Loss Of Consciousness, Ventricular Extrasystoles, Ventricular Fibrillation
Patient was taking Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, ventricular extrasystoles, ventricular fibrillation on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with breast cancer recurrent and. Xeloda dosage: .

6894883-3 | Diarrhoea, Vomiting
Adverse event was reported on Jul 30, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: 4 Daily 2 Morning 2 Night) was diagnosed with neoplasm malignant and. Location: UNITED STATES , weighting 165.0 lb, Patient had the following side effects: diarrhoea, vomiting. Patient was hospitalized.

6887805-2 | Haemolytic Uraemic Syndrome, Sepsis
on Jul 23, 2010 Female patient from GERMANY , 75 years of age, weighting 242.5 lb, was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: haemolytic uraemic syndrome, sepsis (What is sepsis?). Xeloda dosage: .

6887737-X | Psoriasis
on Jul 30, 2010 Male patient from CHINA , 69 years of age, was diagnosed with rectal cancer and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: psoriasis. Xeloda dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6887659-4 | Malignant Neoplasm Progression, Multi-organ Failure, Paraesthesia
Patient was taking Xeloda (View Usage). Patient had the following side effects: malignant neoplasm progression, multi-organ failure, paraesthesia on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 155.4 lb, . Xeloda dosage: 2 Weeks On; One Week Off.

6882744-5 | Condition Aggravated, Stomatitis
Adverse event was reported on Jul 20, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: ) . Location: VENEZUELA , weighting 70.55 lb, After Xeloda was administered, patient had the following side effects: condition aggravated, stomatitis. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), RECORMON (Dose: 30000ui) (View Recormon Review and Recormon Label ).

6882652-X | Brain Oedema, Diarrhoea, Vomiting
on Jul 16, 2010 Female patient from JAPAN , 50 years of age, was diagnosed with breast cancer metastatic and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, diarrhoea, vomiting. Xeloda dosage: . During the same period patient was treated with TYKERB (Dosage Is Uncertain.) (View Tykerb Review and Tykerb Label ).

6882638-5 | Confusional State, Decreased Appetite, Fall, Fatigue, Somnolence, Urinary Incontinence
on Jul 20, 2010 Male patient from UNITED STATES , weighting 203.9 lb, was diagnosed with insomnia, carcinoid tumour, pain (What is pain?) and was treated with Xeloda (View Usage). Patient had the following side effects: confusional state, decreased appetite, fall (What is fall?), fatigue, somnolence, urinary incontinence (What is urinary incontinence?). Xeloda dosage: . During the same period patient was treated with AMBIEN (Frequency: As Necessary At Night) (View Ambien Review and Ambien Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NORVASC (View Norvasc Review and Norvasc Label ), LASIX (View Lasix Review and Lasix Label ).

6876855-8 | Anal Fistula
Patient was taking Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: anal fistula on Jul 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 180.3 lb, . Xeloda dosage: Last Dose: 02 June 2010. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), OXALIPLATIN (Last Dose: 02 June 2010) (View Oxaliplatin Review and Oxaliplatin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ERBITUX (View Erbitux Review and Erbitux Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ).

6876730-9 | Altered State Of Consciousness, Cerebrovascular Accident, Cough, Expressive Language Disorder
Adverse event was reported on Jul 23, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: Treatment Interrupted Many Times.) . Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, cerebrovascular accident, cough, expressive language disorder.

6876719-X | International Normalised Ratio Increased
on Jul 22, 2010 Female patient from FRANCE , 79 years of age, was diagnosed with neoplasm, cerebrovascular accident and was treated with Xeloda (View Usage). Patient had the following side effects: international normalised ratio increased. Xeloda dosage: Form:coated Tablet, First Cycle. During the same period patient was treated with PREVISCAN (Form Reported: Divisible Tablet,) (View Previscan Review and Previscan Label ), CRESTOR (Form Reported: Coated Tablet) (View Crestor Review and Crestor Label ), KERLONE (View Kerlone Review and Kerlone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ).

6876683-3 | Anal Fistula
on Jul 14, 2010 Male patient from UNITED STATES , weighting 180.3 lb, was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: anal fistula. Xeloda dosage: Last Dose: 02 June 2010. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), OXALIPLATIN (Last Dose: 02 June 2010) (View Oxaliplatin Review and Oxaliplatin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ERBITUX (View Erbitux Review and Erbitux Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ).

6876670-5 | Adverse Event, Blood Potassium Increased
Patient was taking Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, blood potassium increased on Jul 16, 2010 from JAPAN Additional patient health information: Male patient , weighting 108.0 lb, was diagnosed with large intestine carcinoma, colon cancer metastatic, hypertension and. Xeloda dosage: 2 Weeks Administration Followed By 1 Week Rest. During the same period patient was treated with ELPLAT (Dosage Is Uncertain.) (View Elplat Review and Elplat Label ), PRECIPITATED CALCIUM CARBONATE (View Precipitated Calcium Carbonate Review and Precipitated Calcium Carbonate Label ), SALOBEL (View Salobel Review and Salobel Label ), LASIX (View Lasix Review and Lasix Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIOVAN (View Diovan Review and Diovan Label ).

6871199-2 | Acute Myocardial Infarction, Chest Pain, Coronary Artery Disease
Adverse event was reported on Jul 19, 2010 by a Male patient taking Xeloda (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: UNITED KINGDOM , 71 years of age, Patient had the following side effects: acute myocardial infarction, chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?). During the same period patient was treated with LOPERAMIDE (View Loperamide Review and Loperamide Label ). Patient was hospitalized.

6862760-X | Psoriasis
on Jul 19, 2010 Male patient from CHINA , 69 years of age, was diagnosed with rectal cancer and was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: psoriasis. Xeloda dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6862659-9 | Convulsion, Diarrhoea, Fatigue, Multi-organ Failure, Nausea, Neutropenic Sepsis, Palmar Erythema, Pancytopenia, Rash Pustular
on Jul 13, 2010 Female patient from UNITED KINGDOM , weighting 99.21 lb, was diagnosed with colon cancer, hypertension and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, diarrhoea, fatigue, multi-organ failure, nausea (What is nausea?), neutropenic sepsis, palmar erythema, pancytopenia, rash pustular. Xeloda dosage: . During the same period patient was treated with PIRITON (View Piriton Review and Piriton Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6860779-6 | Ascites, Asthenia, Constipation, Dehydration, Diarrhoea, Dysphonia
Patient was taking Xeloda (View Usage). Patient had the following side effects: ascites, asthenia, constipation (What is constipation?), dehydration, diarrhoea, dysphonia on Jul 19, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with colon cancer and. Xeloda dosage: .

6860418-4 | Diabetic Ketoacidosis, Neutropenic Sepsis
Adverse event was reported on Jul 15, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?) and. Location: UNITED KINGDOM , weighting 111.1 lb, After Xeloda was administered, patient had the following side effects: diabetic ketoacidosis, neutropenic sepsis. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

6856460-X | Abdominal Rigidity, Blister, Diarrhoea, Erythema, Pyrexia, Vomiting
on Jul 08, 2010 Female patient from POLAND , weighting 123.5 lb, was diagnosed with colorectal cancer metastatic and was treated with Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal rigidity, blister, diarrhoea, erythema, pyrexia, vomiting. Xeloda dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

6856414-3 | Diarrhoea, Febrile Neutropenia, Mucous Membrane Disorder, Palmar-plantar Erythrodysaesthesia Syndrome, Pancytopenia, Stomatitis
on Jul 07, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with colon cancer and was treated with Xeloda (View Usage). Patient had the following side effects: diarrhoea, febrile neutropenia, mucous membrane disorder, palmar-plantar erythrodysaesthesia syndrome, pancytopenia, stomatitis. Xeloda dosage: Discontinued. During the same period patient was treated with BIO THREE (Dose: 1 Df.) (View Bio-three Review and Bio-three Label ), MAGNESIUM OXIDE (Dose Form: Powdered Medicine.) (View Magnesium Oxide Review and Magnesium Oxide Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), DAI KENCHU TO (Dose Form: Granulated Powder.) (View Dai-kenchu-to Review and Dai-kenchu-to Label ). Patient was hospitalized.

6844310-7 | No Adverse Event, Suicidal Ideation
Patient was taking Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: no adverse event, suicidal ideation on Jul 05, 2010 from GREECE Additional patient health information: Female patient , 50 years of age, . Xeloda dosage: Dose Reported As 2 G. During the same period patient was treated with ZOFRON (Start Date: July 2010.) (View Zofron Review and Zofron Label ), ZOLOFT (Start Date: July 2010) (View Zoloft Review and Zoloft Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ). Patient was hospitalized.

6840361-7 | Agitation, Asthenia, Delirium, Device Related Infection, Nausea
Adverse event was reported on Jul 13, 2010 by a Male patient taking Xeloda (View Usage) (Dosage: 8500 Mg) . Location: UNITED STATES , weighting 185.4 lb, Patient experienced the following unwanted or unexpected effects: agitation, asthenia, delirium, device related infection, nausea (What is nausea?). During the same period patient was treated with CAMPTOSAR (240 Mg) (View Camptosar Review and Camptosar Label ), ELOXATIN (160 Mg) (View Eloxatin Review and Eloxatin Label ), TPN ELECTROLYTES IN PLASTIC CONTAINER (View Tpn Electrolytes In Plastic Container Review and Tpn Electrolytes In Plastic Container Label ). Patient was hospitalized.

6832070-5 | Anal Fistula
on Jun 30, 2010 Male patient from UNITED STATES , 68 years of age, was treated with Xeloda (View Usage). Patient had the following side effects: anal fistula. Xeloda dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ).

6832023-7 | Dehydration, Diarrhoea
on Jun 29, 2010 Female patient from NETHERLANDS , weighting 138.9 lb, was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: dehydration, diarrhoea. Xeloda dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), EMCOR (View Emcor Review and Emcor Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), QUESTRAN (Frequency: B.i.d Or Q.d.) (View Questran Review and Questran Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), CALCICHEW (View Calcichew Review and Calcichew Label ).

6828380-8 | Feeling Hot, Hyperhidrosis, Lip Swelling, Oropharyngeal Pain
Patient was taking Xeloda (View Usage). Patient experienced the following unwanted or unexpected effects: feeling hot, hyperhidrosis, lip swelling, oropharyngeal pain on Jul 08, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Xeloda dosage: 1800 Mg Bid Po. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), SINGULAIR (View Singulair Review and Singulair Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COQ 10 (View Coq-10 Review and Coq-10 Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), KLOR CON (View Klor-con Review and Klor-con Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ).

6826903-6 | Asthenia, Dehydration, Diarrhoea, Vomiting
Adverse event was reported on Jul 01, 2010 by a Female patient taking Xeloda (View Usage) (Dosage: ) . Location: POLAND , 78 years of age, Patient had the following side effects: asthenia, dehydration, diarrhoea, vomiting. Patient was hospitalized.

6826759-1 | Diabetes Mellitus Inadequate Control, Hypertriglyceridaemia, Hypothyroidism, Palmar-plantar Erythrodysaesthesia Syndrome
on Jul 01, 2010 Male patient from BRAZIL , weighting 183.0 lb, was diagnosed with colon cancer and was treated with Xeloda (View Usage). After Xeloda was administered, patient had the following side effects: diabetes mellitus inadequate control, hypertriglyceridaemia, hypothyroidism, palmar-plantar erythrodysaesthesia syndrome. Xeloda dosage: Frequency: D1 To D14.

6819948-3 |
on Jun 29, 2010 Male patient from ECUADOR , 66 years of age, was diagnosed with gastric cancer and was treated with Xeloda (View Usage). . Xeloda dosage: .

6817105-8 | Diarrhoea, Dihydropyrimidine Dehydrogenase Deficiency, Infection, Mucosal Inflammation, Neutropenia, Perineal Ulceration, Pharyngeal Ulceration, Pyrexia, Thrombocytopenia
Patient was taking Xeloda (View Usage). Patient had the following side effects: diarrhoea, dihydropyrimidine dehydrogenase deficiency, infection (What is infection?), mucosal inflammation, neutropenia, perineal ulceration, pharyngeal ulceration, pyrexia, thrombocytopenia on Jun 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Xeloda dosage: Dose 1500 No Units Provided Twice A Day For 2 Weeks. During the same period patient was treated with OXALIPLATIN (Dose Reported As 200 No Units Provided) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.